PMDA inspection
AstraZeneca Pharmaceuticals LP, Coppell
PMDA inspection 5130608035603 · USA · Suitable
Key facts
| Control number | 5130608035603 |
|---|---|
| Manufacturing site | AstraZeneca Pharmaceuticals LP, Coppell |
| Location | 508 Wrangler Drive, Suite 100, Coppell, Texas 75019, United States |
| Country | USA |
| Product type | Pharmaceuticals |
| Application type | Regular |
| Inspection method | Remote |
| Inspection month | Nov 1, 2024 |
| Result | Suitable |
| Result notified | Nov 25, 2024 |
| PMDA registration | AG30400607 |
About PMDA GMP inspections (Japan)
Japan's PMDA conducts GMP and QMS inspections of domestic and foreign manufacturing sites that supply the Japanese market.
Source: Pharmaceuticals and Medical Devices Agency (PMDA), Japan